WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Steven Gore
Patent Agent
Patents and Innovations
Boulder
sgore@wsgr.com

D303-256-5923

Download vCard
Open PDF

Steven Gore is a patent agent in the Boulder office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property particularly at the intersection of the life science and artificial intelligence.

Prior to joining the firm, Steven completed his Ph.D. in biology focusing on developing AI models for disease detection using epigenomic data. During this time, he developed models capable of detecting multiple cancers and multiple non-infectious diseases from a myriad of human tissue samples. In addition to this work, he developed a novel architecture to discover informative concepts learned by generative models to better explain the model’s behavior.

Steven served in the United States Air Force from 2002-2006 where he was stationed at Eglin AFB as an air armaments systems specialist. There, he maintained munitions systems and loaded munitions on the F-15A-E and A-10 airframes. During that time he also worked closely with engineers from various government DoD contractors to assist in the development of standards and practices for the loading of new, experimental munition. Steven was a part of the 2003 load crew of the year.

Experience

Steven Gore is a patent agent in the Boulder office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property particularly at the intersection of the life science and artificial intelligence.

Prior to joining the firm, Steven completed his Ph.D. in biology focusing on developing AI models for disease detection using epigenomic data. During this time, he developed models capable of detecting multiple cancers and multiple non-infectious diseases from a myriad of human tissue samples. In addition to this work, he developed a novel architecture to discover informative concepts learned by generative models to better explain the model’s behavior.

Steven served in the United States Air Force from 2002-2006 where he was stationed at Eglin AFB as an air armaments systems specialist. There, he maintained munitions systems and loaded munitions on the F-15A-E and A-10 airframes. During that time he also worked closely with engineers from various government DoD contractors to assist in the development of standards and practices for the loading of new, experimental munition. Steven was a part of the 2003 load crew of the year.

Education
  • Ph.D., Biology, University of North Texas, 2023

    First Place for 3 Minute Thesis, 2019

  • B.S., Biology, University of North Texas, 2010
Admissions
  • U.S. Patent and Trademark Office
Credentials
Education
  • Ph.D., Biology, University of North Texas, 2023

    First Place for 3 Minute Thesis, 2019

  • B.S., Biology, University of North Texas, 2010
Admissions
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author with R.K. Azad, "CancerNet: a unified deep learning network for pan-cancer diagnostics," 23(1) BMC Bioinformatics 1-17, 2022
Insights

Select Publications

  • Co-author with R.K. Azad, "CancerNet: a unified deep learning network for pan-cancer diagnostics," 23(1) BMC Bioinformatics 1-17, 2022

Biological Sciences and Biotechnology

  • Cancer biology
  • Cancer therapeutics
  • Epigenetics
  • Genetics
  • Genomics
  • Molecular biology
  • Molecular genetics

Therapeutics and Drug Discovery

  • CRISPR
  • Drug conjugates
  • Drug delivery
  • Gene editing
  • Gene therapy
  • RNA interference (RNAi)
  • Vaccines

Diagnostics and Medical Devices

  • Bioinformatic
  • Diagnostics
  • Medical imaging

Engineering and Technology

  • AI
  • Computer science
  • Machine learning

Genomics and Data Analysis

  • Bioinformatics algorithms
  • Computational biology
  • Functional genomics
  • Next-generation sequencing
  • Sequencing
  • Single-cell sequencing

Miscellaneous

  • Cancer
Technical Fluency

Biological Sciences and Biotechnology

  • Cancer biology
  • Cancer therapeutics
  • Epigenetics
  • Genetics
  • Genomics
  • Molecular biology
  • Molecular genetics

Therapeutics and Drug Discovery

  • CRISPR
  • Drug conjugates
  • Drug delivery
  • Gene editing
  • Gene therapy
  • RNA interference (RNAi)
  • Vaccines

Diagnostics and Medical Devices

  • Bioinformatic
  • Diagnostics
  • Medical imaging

Engineering and Technology

  • AI
  • Computer science
  • Machine learning

Genomics and Data Analysis

  • Bioinformatics algorithms
  • Computational biology
  • Functional genomics
  • Next-generation sequencing
  • Sequencing
  • Single-cell sequencing

Miscellaneous

  • Cancer
Focus Areas
  • Artificial Intelligence and Machine Learning
  • Diagnostics, Life Science Tools, and Deep Tech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises PrognomiQ on Patent Matters Related to $34 Million Series D
On November 5, 2024, PrognomiQ, a healthcare company focused on harnessing the power of multi-omics data to transform the detection and early treatment selection and monitoring of cancer and other complex diseases, announced the succesful completion of a $34 million Series D financing. The round was led by Seer with participation from Catalio Capital Management, aMoon, Invus, and Bruker. Wilson Sonsini Goodrich & Rosati advised PrognomiQ on patent matters related to the transaction.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.